Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Fascioliasis

  • Chapter
  • First Online:
Helminth Infections and their Impact on Global Public Health

Abstract

Human fascioliasis is an important public health problem in many regions and livestock infection is a veterinary problem worldwide. This disease is caused by the liver fluke species Fasciola hepatica of worldwide distribution and F. gigantica restricted to regions of Africa and Asia. Their two-host life cycle is similar, including specific freshwater lymnaeid snails as vectors. The major human health problems are known in Andean countries, the Caribbean, Northern Africa, Near East, Southeast Asia and Western Europe. In human hyperendemic areas, children and females are the most affected. Human fascioliasis shows a marked heterogeneity of epidemiological situations and transmission patterns. Variation of climatic factors and anthropogenic environmental modifications give rise to different fascioliasis seasonality and long-term disease risk trends. There are many human infection sources, local diet and cultural traditions being important. The rapid and potent ability of fasciolids to suppress the immune response explains why hosts do not develop resistance and the frequency of pathogen coinfections. The disease is chiefly confined to the liver, including hepatic lesions, fibrosis and chronic inflammation. Juvenile flukes may cause ectopic fascioliasis. Clinical manifestations are evident in both invasive and biliary periods. Diagnosis is mainly made by coprological and serological techniques. Among the useful drugs, triclabendazole is of choice at present. Prognosis depends on treatment promptness. Serious complications, sequelae and death causes should be highlighted. New knowledge has allowed improvement of individual infection prevention measures and community control. Challenges appear in vaccinology, indicating that a human vaccine is still far from affordable.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Acosta-Ferreira W, Vercelli-Retta J, Falconi LM (1979) Fasciola hepatica human infection. Histopathological study of sixteen cases. Virchows Arch A Pathol Anat Histol 383:319–327

    Article  CAS  PubMed  Google Scholar 

  • Afshan K, Fortes-Lima CA, Artigas P, Valero MA, Qayyum M, Mas-Coma S (2014) Impact of climate change and man-made irrigation systems on the transmission risk, long-term trend and seasonality of human and animal fascioliasis in Pakistan. Geospatial Health (in press)

    Google Scholar 

  • Apt W, Aguilera X, Vega F, Miranda C, Zulantay I, Perez C, Gabor M, Apt P (1995) Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 52:532–535

    CAS  PubMed  Google Scholar 

  • Arjona R, Riancho JA, Aguado JM, Salesa R, Gonzalez-Macias J (1995) Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine (Baltimore) 74:13–23

    Article  CAS  Google Scholar 

  • Artigas P, Bargues MD, Mera y Sierra R, Agramunt VH, Mas-Coma S (2011) Characterisation of fascioliasis lymnaeid intermediate hosts from Chile by DNA sequencing, with emphasis on Lymnaea viator and Galba truncatula. Acta Trop 120:245–257

    Article  PubMed  Google Scholar 

  • Ashrafi K, Valero MA, Massoud J, Sobhani AR, Solaymani-Mohammadi S, Conde P, Khoubbane M, Bargues MD, Mas-Coma S (2006) Plant-borne human contamination by fascioliasis. Am J Trop Med Hyg 75:295–302

    PubMed  Google Scholar 

  • Bargues MD, Vigo M, Horak P, Dvorak J, Patzner RA, Pointier JP, Jackiewicz M, Meier-Brook C, Mas-Coma S (2001) European Lymnaeidae (Mollusca: Gastropoda), intermediate hosts of trematodiases, based on nuclear ribosomal DNA ITS-2 sequences. Infect Genet Evol 1:85–107

    Article  CAS  PubMed  Google Scholar 

  • Bargues MD, Artigas P, Mera y Sierra RL, Pointier JP, Mas-Coma S (2007) Characterisation of Lymnaea cubensis, L. viatrix and L. neotropica n. sp., the main vectors of Fasciola hepatica in Latin America, by analysis of their ribosomal and mitochondrial DNA. Ann Trop Med Parasitol 101:621–641

    Article  CAS  PubMed  Google Scholar 

  • Bargues MD, Artigas P, Khoubbane M, Flores R, Glöer P, Rojas-Garcia R, Ashrafi K, Falkner G, Mas-Coma S (2011a) Lymnaea schirazensis, an overlooked snail distorting fascioliasis data: genotype, phenotype, ecology, worldwide spread, susceptibility, applicability. PLoS ONE 6(9):e24567 (33 pp. + 3 Suppl. Tables + 5 Suppl. Figures)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bargues MD, Gonzalez C, Artigas P, Mas-Coma S (2011b) A new baseline for fascioliasis in Venezuela: lymnaeid vectors ascertained by DNA sequencing and analysis of their relationships with human and animal infection. Parasit Vectors 4:200 (18 pp.)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bargues MD, Artigas P, Khoubbane M, Mas-Coma S (2011c) DNA sequence characterisation and phylogeography of Lymnaea cousini and related species, vectors of fascioliasis in northern Andean countries, with description of L. meridensis n. sp. (Gastropoda: Lymnaeidae). Parasit Vectors 4:132 (22 pp.)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Brady MT, O’Neill SM, Dalton JP, Mills KH (1999) Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect Immun 67:5372–5378

    CAS  PubMed Central  PubMed  Google Scholar 

  • Carnevale S, Rodriguez MI, Guarnera EA, Carmona C, Tanos T, Angel SO (2001) Immunodiagnosis of fasciolosis using recombinant procathepsin L cysteine proteinase. Diagn Microbiol Infect Dis 41:43–49

    Article  CAS  PubMed  Google Scholar 

  • Chen MG, Mott KE (1990) Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull 87:R1–R38

    Google Scholar 

  • Curtale F, Mas-Coma S, Hassanein YAE, Barduagni P, Pezzotti P, Savioli L (2003) Clinical signs and household characteristics associated with human fascioliasis among rural population in Egypt: a case-control study. Parassitologia 45:5–11

    CAS  PubMed  Google Scholar 

  • Dalton JP, McConigle S, Rolph TP, Andrews SJ (1996) Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infect Immun 64:5066–5074

    CAS  PubMed Central  PubMed  Google Scholar 

  • Dalton JP, Robinson MW, Mulcahy G, O’Neill SM, Donnelly S (2013) Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development. Vet Parasitol 195:272–285

    Article  CAS  PubMed  Google Scholar 

  • Del Risco BU, Vazquez Drake CT, Garcia Gonzalez G, Sanchen Casa A (2001) Evaluación de la excreción de huevos de Fasciola hepatica por tres esquemas terapéuticos. Rev Electr Arch Méd Camagüey 5:4

    Google Scholar 

  • El-Morshedy H, Farghaly A, Sharaf S, Abou-Basha L, Barakat R (1999) Triclabendazole in the treatment of human fascioliasis: a community-based study. East Mediterr Health J 5:888–894

    CAS  PubMed  Google Scholar 

  • Espinoza JR, Maco V, Marcos L, Saez S, Neyra V, Terashima A, Samalvides F, Gotuzzo E, Chavarry E, Huaman C, Bargues MD, Valero MA, Mas-Coma S (2007) Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg 76:977–982

    CAS  PubMed  Google Scholar 

  • Esteban JG, Flores A, Aguirre C, Strauss W, Angles R, Mas-Coma S (1997a) Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the Northern Bolivian Altiplano. Acta Trop 66:1–14

    Article  CAS  PubMed  Google Scholar 

  • Esteban JG, Flores A, Angles R, Strauss W, Aguirre C, Mas-Coma S (1997b) A population-based coprological study of human fascioliasis in a hyperendemic area of the Bolivian Altiplano. Trop Med Int Health 2:695–699

    Article  CAS  PubMed  Google Scholar 

  • Esteban JG, Bargues MD, Mas-Coma S (1998) Geographical distribution, diagnosis and treatment of human fascioliasis: a review. Res Rev Parasitol 58:13–42

    Google Scholar 

  • Esteban JG, Flores A, Angles R, Mas-Coma S (1999) High endemicity of human fascioliasis between Lake Titicaca and La Paz valley, Bolivia. Trans R Soc Trop Med Hyg 93:151–156

    Article  CAS  PubMed  Google Scholar 

  • Esteban JG, Gonzalez C, Bargues MD, Angles R, Sanchez C, Naquira C, Mas-Coma S (2002) High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop Med Int Health 7:339–348

    Article  PubMed  Google Scholar 

  • Esteban JG, Gonzalez C, Curtale F, Muñoz-Antoli C, Valero MA, Bargues MD, El Sayed M, El Wakeel A, Abdel-Wahab Y, Montresor A, Engels D, Savioli L, Mas-Coma S (2003) Hyperendemic fascioliasis associated with schistosomiasis in villages of the Nile Delta, Egypt. Am J Trop Med Hyg 69:429–437

    PubMed  Google Scholar 

  • Favennec L, Jave Ortiz J, Gargala G, Lopez Chegne N, Ayoub A (2003) Double blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment Pharmacol Ther 17:265–270

    Article  CAS  PubMed  Google Scholar 

  • Gargala G, Abboud P, Borsa-Lebas F, Courchay E, Koning E, Favennec L, Caron F (2005) Case report of successful treatment of triclabendazole resistant fascioliasis by nitazoxanide. In: Medicine and health in the tropics. (XVIth International Congress for Tropical Medicine and Malaria, Marseille, France, 11-15 Sept. 2005), Abstract Book, P680, 283

    Google Scholar 

  • Gil-Benito A, Ciolkovitch A, Mas-Coma S, Quilici M (1991) Enquête sur la distomatose à Fasciola hepatica en Corse. Méditerranée Médicale (Marseille) 403:21–25

    Google Scholar 

  • Girones N, Valero MA, Garcia-Bodelon MA, Chico-Calero MI, Punzon C, Fresno M, Mas-Coma S (2007) Immune suppression in advanced chronic fascioliasis: an experimental study in a rat model. J Infect Dis 195:1504–1512

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez LC, Esteban JG, Bargues MD, Valero MA, Ortiz P, Naquira C, Mas-Coma S (2011) Hyperendemic human fascioliasis in Andean valleys: an altitudinal transect analysis in children of Cajamarca province, Peru. Acta Trop 120:119–129

    Article  PubMed  Google Scholar 

  • Hillyer GV (1999) Immunodiagnosis of human and animal fasciolosis. In: Dalton JP (ed) Fasciolosis. CAB International Publishing, Wallingford, Oxon, UK, pp 435–447

    Google Scholar 

  • Intapan PM, Mallewong W, Wongkham C, Tomanakarn K, Ieamviteevanich K, Pipitgool V, Sukolapong V (1998) Excretory-secretory antigen components of adult Fasciola gigantica recognized by infected human sera. Southeast Asian J Trop Med Public Health 29:579–583

    CAS  PubMed  Google Scholar 

  • Jaffar Z, Sivakuru T, Roberts K (2004) CD4(+)CD25(+) T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J Immunol 172:3842–3849

    Article  CAS  PubMed  Google Scholar 

  • Kabil SM, El Ashry E, Ashraf NK (2000) An open-label clinical study of nitazoxanide in the treatment of human fascioliasis. Curr Ther Res 61:339–345

    Article  CAS  Google Scholar 

  • Lecaillon JB, Gobdillon J, Campestrini J (1998) Effect of food on bioavailability of triclabendazole in patients with fascioliasis. Br J Clin Pharmacol 45:601–604

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Maggioli G, Acosta D, Silveira F, Rossi S, Giacaman S, Basika T, Gayo V, Rosadilla D, Roche L, Tort J, Carmona C (2011) The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica in sheep. Vaccine 29:9057–9063

    Article  CAS  PubMed  Google Scholar 

  • Maleewong W, Wongkham C, Intapan PM, Pipitgol V (1999) Fasciola gigantica-specific antigens: purification by a continuous-elution method and its evaluation for the diagnosis of human fascioliasis. Am J Trop Med Hyg 61:648–651

    CAS  PubMed  Google Scholar 

  • Marcos Raymundo LA, Maco Flores V, Terashima Iwashita A, Samalvides Cuba F, Gotuzzo Herencia E (2002) Características clínicas de la infección crómica por Fasciola hepatica en niños. Rev Gastroenterol Peru 22:228–233

    PubMed  Google Scholar 

  • Marcos LA, Busalleu A, Terashima A, Espinoza JR (2009) Detection of antibodies against Fasciola hepatica in cirrhotic patients from Peru. J Helminthol 83:23–26

    Article  CAS  PubMed  Google Scholar 

  • Martinez-Sernandez V, Muiño L, Perteguer MJ, Garate T, Mezo M, Gonzalez-Warleta M, Muro A, Correia da Costa JM, Romaris F, Ubeira FM (2011) Development and evaluation of a new lateral flow Immunoassay for serodiagnosis of human fasciolosis. PLoS Negl Trop Dis 5(11):e1376

    Article  PubMed Central  PubMed  Google Scholar 

  • Mas-Coma S (2004) Human fascioliasis. In: Cotruvo JA, Dufour A, Rees G, Bartram J, Carr R, Cliver DO, Craun GF, Fayer R, Gannon VPJ (eds) World Health Organization (WHO), waterborne zoonoses: identification, causes and control. IWA Publishing, London, UK, pp 305–322

    Google Scholar 

  • Mas-Coma S (2005) Epidemiology of fascioliasis in human endemic areas. J Helminthol 79:207–216

    Article  CAS  PubMed  Google Scholar 

  • Mas-Coma S, Bargues MD (1997) Human liver flukes: a review. Res Rev Parasitol 57:145–218

    Google Scholar 

  • Mas-Coma S, Esteban JG, Bargues MD (1999a) Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 77:340–346

    CAS  PubMed Central  PubMed  Google Scholar 

  • Mas-Coma S, Bargues MD, Esteban JG (1999b) Human Fasciolosis. In: Dalton JP (ed) Fasciolosis. CAB International Publishing, Wallingford, Oxon, UK, pp 411–434

    Google Scholar 

  • Mas-Coma S, Angles R, Esteban JG, Bargues MD, Buchon P, Franken M, Strauss W (1999c) The Northern Bolivian Altiplano: a region highly endemic for human fascioliasis. Trop Med Int Health 4:454–467

    Article  CAS  PubMed  Google Scholar 

  • Mas-Coma S, Bargues MD, Marty AM, Neafie RC (2000) Hepatic trematodiases. In: Meyers WM, Neafie RC, Marty AM, Wear DJ (eds) Pathology of infectious diseases, vol 1, Helminthiases. Armed Forces Institute of Pathology and American Registry of Pathology, Washington DC, pp 69–92

    Google Scholar 

  • Mas-Coma S, Bargues MD, Valero MA, Fuentes MV (2003) Adaptation capacities of Fasciola hepatica and their relationships with human fascioliasis: from below sea level up to the very high altitude. In: Combes C, Jourdane J (eds) Taxonomy, ecology and evolution of metazoan parasites, vol 2. Presses Universitaires de Perpignan, Perpignan, pp 81–123

    Google Scholar 

  • Mas-Coma S, Bargues MD, Valero MA (2005) Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol 35:1255–1278

    Article  CAS  PubMed  Google Scholar 

  • Mas-Coma S, Bargues MD, Valero MA (2007) Plantborne trematode zoonoses fascioliasis and fasciolopsiasis. In: Murrell D, Fried B (eds) World class parasites, vol 11, Food-borne parasites, fish and plant-borne parasites. Springer, New York, pp 293–334

    Google Scholar 

  • Mas-Coma S, Valero MA, Bargues MD (2009a) Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol 69:41–146

    Article  PubMed  Google Scholar 

  • Mas-Coma S, Valero MA, Bargues MD (2009b) Climate change effects on trematodiases, with emphasis on zoonotic fascioliasis and schistosomiasis. Vet Parasitol 163:264–280

    Article  PubMed  Google Scholar 

  • Mas-Coma S, Agramunt VH, Valero MA (2013) Direct and indirect affection of the central nervous system by Fasciola infection. Handb Clin Neurol 114:297–310

    Article  PubMed  Google Scholar 

  • Mas-Coma S, Agramunt VH, Valero MA (2014) Neurological and ocular fascioliasis in humans. Adv Parasitol 84:27–149

    Google Scholar 

  • Mezo M, Gonzalez-Warleta M, Carro C, Ubeira FM (2004) An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3). J Parasitol 90:845–852

    Article  PubMed  Google Scholar 

  • Millan JC, Mull R, Freise S, Richter J (2000) The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection. Am J Trop Med Hyg 63:264–269

    CAS  PubMed  Google Scholar 

  • O’Neill SM, Parkinson SM, Dowd AJ, Strauss W, Angles R, Dalton JP (1999) Immunodiagnosis of human fascioliasis using recombinant Fasciola hepatica cathepsin L1 cysteine proteinase. Am J Trop Med Hyg 60:749–751

    PubMed  Google Scholar 

  • O’Neill SM, Brady MT, Callanan JJ, Mulcahy G, Joyce P, Mills KH, Dalton JP (2000) Fasciola hepatica infection downregulates Th1 responses in mice. Parasite Immunol 22:147–155

    Article  PubMed  Google Scholar 

  • Olaechea F, Lovera V, Larroza M, Raffo F, Cabrera R (2011) Resistance of Fasciola hepatica against Triclabendazole in cattle in Patagonia (Argentina). Vet Parasitol 178:364–366

    Article  CAS  PubMed  Google Scholar 

  • Oliveira DR, Ferreira DM, Stival CC, Romero F, Cavagnolli F, Kloss A, Araujo F, Molento MB (2008) Triclabendazole resistance involving Fasciola hepatica in sheep and goats during an outbreak in Almirante Tamandare, Parana, Brazil. Rev Brasil Parasitol Vet 17(Suppl 1):149–153

    Google Scholar 

  • Ortiz P, Scarcella S, Cerna C, Rosales C, Cabrera M, Guzman M, Lamenza P, Solana H (2013) Resistance of Fasciola hepatica against triclabendazole in cattle in Cajamarca (Peru): a clinical trial and in vive efficacy test in sheep. Vet Parasitol 195:118–121. doi:10.1016/j.vetpar.2013.01.001

    Article  CAS  PubMed  Google Scholar 

  • Periago MV, Valero MA, Panova M, Mas-Coma S (2006) Phenotypic comparison of allopatric populations of Fasciola hepatica and Fasciola gigantica from European and African bovines using a computer image analysis system (CIAS). Parasitol Res 99:368–378

    Article  CAS  PubMed  Google Scholar 

  • Piacenza L, Acosta D, Basmadjian L, Dalton JP, Carmona C (1999) Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep. Infect Immun 67:1954–1961

    CAS  PubMed Central  PubMed  Google Scholar 

  • Robinson MW, Dalton JP, O'Brien BA, Donelly S (2013) Fasciola hepatica: the therapeutic potential of a worm secretome. Int J Parasitol 43:283–291

    Article  CAS  PubMed  Google Scholar 

  • Rossignol JF, Abaza H, Friedman H (1998) Successful treatment of human fascioliasis with nitazoxanide. Trans R Soc Trop Med Hyg 92:103–104

    Article  CAS  PubMed  Google Scholar 

  • Savioli L, Chistulo L, Montresor A (1999) New opportunities for the control of fascioliasis. Bull World Health Organ 77:300

    CAS  PubMed Central  PubMed  Google Scholar 

  • Spithill TW, Carmona C, Piedrafita D, Smooker PM (2012) Prospects for immunoprophylaxis against Fasciola hepatica (liver fluke). In: Caffrey CR, Selzer PM (eds) Parasitic Helminths: targets, screens, drugs and vaccines. Wiley, Germany

    Google Scholar 

  • Strauss W, O’Neill SM, Parkinson M, Angles R, Dalton JP (1999) Diagnosis of human fascioliasis: detection of anti-cathepsin L antibodies in blood samples collected on filter paper. Am J Trop Med Hyg 60:746–748

    CAS  PubMed  Google Scholar 

  • Talaie H, Emami H, Yadegarinia D, Nava-Ocampo AA, Massoud J, Azmoudeh M, Mas-Coma S (2004) Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis. Clin Exp Pharmacol Physiol 31:777–782

    Article  CAS  PubMed  Google Scholar 

  • Tantrawatpan C, Maleewong W, Wongkham C, Wongkham S, Intapan PM, Nakashima K (2005) Serodiagnosis of human fascioliasis by cystatin capture enzyme-linked immunosorbent assay with recombinant Fasciola gigantica cathepsin L antigen. Am J Trop Med Hyg 72:82–86

    CAS  PubMed  Google Scholar 

  • Ubeira FM, Muiño L, Valero MA, Periago MV, Perez-Crespo I, Mezo M, Gonzalez-Warleta M, Romaris F, Paniagua E, Cortizo S, Llovo J, Mas-Coma S (2009) MM3-ELISA detection of Fasciola hepatica coproantigens in preserved human stool samples. Am J Trop Med Hyg 81:156–162

    PubMed  Google Scholar 

  • Valero MA, Mas-Coma S (2000) Comparative infectivity of Fasciola hepatica metacercariae from isolates of the main and secondary reservoir animal host species in the Bolivian Altiplano high human endemic region. Folia Parasitol 47:17–22

    Article  CAS  PubMed  Google Scholar 

  • Valero MA, Santana M, Morales M, Hernandez JL, Mas-Coma S (2003) Risk of gallstone disease in advanced chronic phase of fascioliasis: an experimental study in a rat model. J Infect Dis 188:787–793

    Article  PubMed  Google Scholar 

  • Valero MA, De Renzi M, Panova M, Garcia-Bodelon MA, Periago MV, Ordoñez D, Mas-Coma S (2006a) Crowding effect on adult growth, pre-patent period and egg shedding of Fasciola hepatica. Parasitology 133:453–463

    Article  CAS  PubMed  Google Scholar 

  • Valero MA, Navarro M, Garcia-Bodelon MA, Marcilla A, Morales M, Garcia JE, Hernandez JL, Mas-Coma S (2006b) High risk of bacterobilia in advanced experimental chronic fasciolosis. Acta Trop 100:17–23

    Article  CAS  PubMed  Google Scholar 

  • Valero MA, Girones N, Garcia-Bodelon MA, Periago MV, Chico-Calero I, Khoubbane M, Fresno M, Mas-Coma S (2008) Anaemia in advanced chronic fasciolosis. Acta Trop 108:35–43

    Article  CAS  PubMed  Google Scholar 

  • Valero MA, Perez-Crespo I, Periago MV, Khoubbane M, Mas-Coma S (2009) Fluke egg characteristics for the diagnosis of human and animal fascioliasis by Fasciola hepatica and F. gigantica. Acta Trop 111:150–159

    Article  PubMed  Google Scholar 

  • Valero MA, Periago MV, Perez-Crespo I, Angles R, Villegas F, Aguirre C, Strauss W, Espinoza JR, Herrera P, Terashima A, Tamayo H, Engels D, Gabrielli AF, Mas-Coma S (2012a) Field evaluation of a coproantigen detection test for fascioliasis diagnosis and surveillance in human hyperendemic areas of Andean countries. PLoS Negl Trop Dis 6(9):e1812 (11 pp.)

    Article  PubMed Central  PubMed  Google Scholar 

  • Valero MA, Periago MV, Perez-Crespo I, Rodriguez E, Perteguer MJ, Garate T, Gonzalez-Barbera EM, Mas-Coma S (2012b) Assessing the validity of an ELISA test for the serological diagnosis of human fascioliasis in different epidemiological situations. Trop Med Int Health 17:630–636

    Article  CAS  PubMed  Google Scholar 

  • Valero MA, Perez-Crespo I, Khoubbane M, Artigas P, Panova M, Ortiz P, Maco V, Espinoza JR, Mas-Coma S (2012c) Fasciola hepatica phenotypic characterisation in Andean human endemic areas: valley versus altiplanic patterns analysed in liver flukes from sheep from Cajamarca and Mantaro, Peru. Infect Genet Evol 12:403–410

    Article  PubMed  Google Scholar 

  • Villegas F, Angles R, Barrientos R, Barrios G, Valero MA, Hamed K, Grueningr H, Ault SK, Montresor A, Engels D, Mas-Coma S, Gabrielli AF (2012) Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano. PLoS Negl Trop Dis 6(8):e1720

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Winkelhagen AJS, Mank T, de Vries PJ, Soetekouw R (2012) Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands. Emerg Infect Dis 18:1028–1029

    Article  PubMed Central  PubMed  Google Scholar 

  • World Health Organization (2007) Report of the WHO Informal Meeting on use of triclabendazole in fascioliasis control. World Health Organization, Headquarters Geneva, 17–18 October 2006: WHO/CDS/NTD/PCT/2007.1

    Google Scholar 

  • World Health Organization (2008) Fact sheet on fascioliasis. In: Action against worms, World Health Organization, Headquarters Geneva (December 2007), Newsletter 10:1–8

    Google Scholar 

  • World Health Organization (2013) Sustaining the drive to overcome the global impact of neglected tropical diseases. World Health Organization, WHO Headquarters, Geneva, 138 pp

    Google Scholar 

  • Zumaquero-Ríos JL, Sarracent-Pérez J, Rojas-García R, Rojas-Rivero L, Martínez-Tovilla Y, Valero MA, Mas-Coma S (2013) Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide. PLoS Negl Trop Dis 7:e2553

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgements

The review of human fascioliasis is carried out within projects SAF2010-20805 of the Ministry of Economy and Competitiveness, Madrid, Spain; ISCIII-RETIC RD12/0018/0013, Red de Investigación de Centros de Enfermedades Tropicales (RICET), of the programme of Redes Temáticas de Investigación Cooperativa RETICS/FEDER, Ministry of Health and Consumption, Madrid, Spain; and PROMETEO/2012/042 of the programme of Ayudas para Grupos de Investigación de Excelencia, Generalitat Valenciana, Valencia, Spain.

Author information

Authors and Affiliations

  1. Departamento de Parasitologia, Facultad de Farmacia, Universidad de Valencia, Av. Vicent Andres Estelles s/n, 46100, Burjassot, Valencia, Spain

    S. Mas-Coma, M. D. Bargues & M. A. Valero

Authors
  1. S. Mas-Coma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. D. Bargues
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. Valero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Mas-Coma .

Editor information

Editors and Affiliations

  1. Dipartimento di Ricerca Traslazionale, Università di Pisa, Pisa, Italy

    Fabrizio Bruschi

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Wien

About this chapter

Cite this chapter

Mas-Coma, S., Bargues, M.D., Valero, M.A. (2014). Fascioliasis. In: Bruschi, F. (eds) Helminth Infections and their Impact on Global Public Health. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1782-8_4

Download citation

Publish with us

Policies and ethics

Search

Navigation